According to ORIC Pharmaceuticals
's latest financial reports the company has NZ$0.33 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$0.45 B | 37.86% |
2023-12-31 | NZ$0.32 B | 1.33% |
2022-12-31 | NZ$0.32 B | -6.36% |
2021-12-31 | NZ$0.34 B | -14.74% |
2020-12-31 | NZ$0.40 B | 207.36% |
2019-12-31 | NZ$0.13 B | 108.28% |
2018-12-31 | NZ$63.56 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | NZ$0.33 B | 0.00% | ๐บ๐ธ USA |